Sipai Health Technology Co. Ltd.

Sipai Health Technology Co. Ltd.

AX1 · F · Healthcare / Medical Distribution

0.159EUR-0.01 (-5.92%)

Price History

Full chart

Market Stats

Previous Close0.169
Open0.159
Day Range0.159 – 0.159
52-Week Range0.109 – 0.334
Volume0
Market Cap108.80M
P/E (TTM)0.00
Forward P/E0.00
EPS0.00
Dividend Yield0.00%
Beta-0.56
50-Day Avg0.1453
200-Day Avg0.1787

About

Sipai Health Technology Co., Ltd., together with its subsidiaries, operates as a medical technology and health management company in the People's Republic of China. It operates through three segments: Specialty Pharmacy Business, Physician Research Assistance Business, and Commercial Insurance Services Business. The company operates specialty pharmacy stores; and distributes pharmaceutical products to pharmaceutical companies and other distributors. It also provides site management organization services, including site feasibility, site initiation, patient recruitment, patient management, data entry and document management, on-site drug management and bio-sample management, site closure, and other services to pharmaceutical companies and other clinical trial institutions; and services for image management in clinical trials. In addition, the company offers insurance brokerage services to insurance companies and health management services to insurance carriers and enterprise clients. Further, it is involved in retail of pharmaceutical products; and provision of pharmacist and physician research assistance services. The company was founded in 2014 and is based in Shanghai, the People's Republic of China.

Company Details

  • SectorHealthcare
  • IndustryMedical Distribution
  • CEOMr. Xuguang Ma
  • Employees3.45K
  • HeadquartersTower 1, Kerry Enterprise Center, Shanghai, China, Germany
  • Websitehttps://www.medbankshealthtech.com

Leadership

  • Mr. Xuguang MaCEO & Executive Chairman · b. 1971
  • Mr. Ji LiPresident & Executive Director · b. 1978
  • Ms. Na RenGeneral Counsel & Company Secretary · b. 1978

Financials

Income Statement

Currency: CNY2021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue3.47B4.12B4.71B4.57B2.07B
Growth (%)-+18.58%+14.39%-3.11%-54.64%
Cost of Revenue3.19B3.78B4.30B4.18B1.76B
Gross Profit283.45M337.35M414.70M386.43M311.32M
Gross Margin8.16%8.19%8.80%8.46%15.03%
Operating Expense1.01B950.36M660.73M666.02M403.65M
Operating Income-728.02M-613.00M-246.03M-279.59M-92.33M
Operating Margin-20.96%-14.88%-5.22%-6.12%-4.46%
EBITDA--1.31B-189.21M-308.80M-99.84M
EBITDA Margin--31.92%-4.02%-6.76%-4.82%
Net Income-3.74B-1.37B-255.77M-323.74M-124.27M
Net Income Margin-107.67%-33.27%-5.43%-7.09%-6.00%
R&D59.21M62.65M45.95M22.26M10.20M
R&D as % of Total Revenue1.70%1.52%0.98%0.49%0.49%
Interest Expense3.69M4.04M3.49M3.07M1.43M
Interest Expense % of Total Revenue0.11%0.10%0.07%0.07%0.07%

Balance Sheet

Currency: CNY2021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets2.89B2.93B2.82B2.27B1.60B
Total Liabilities8.32B1.10B1.18B1.06B702.90M
Total Equity-5.43B1.84B1.62B1.23B936.31M
Cash535.85M1.46B495.43M252.92M259.14M
Net Debt6.90B----

Cash Flow

Currency: CNY2021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-621.92M-182.07M-133.50M-59.45M6.36M
Capital Expenditure21.41M11.80M5.75M10.70M6.23M
Free Cash Flow-643.33M-193.87M-139.24M-70.15M127.00K
FCF to OCF103.44%106.48%104.31%118.01%2.00%

Key Statistics & Ratios

Market Cap108.80M
Enterprise Value65.59M
Trailing P/E0.00
Forward P/E0.00
Price / Sales0.07
Price / Book0.92
EPS0.00
Book Value0.1674
Revenue (TTM)1.59B
Gross Profit (TTM)282.63M
EBITDA-21.20M
Profit Margin-0.57%
Operating Margin-0.52%
Return on Equity-0.29%
Return on Assets-1.29%
Shares Outstanding725.33M
Shares Float333.81M
Beta-0.56
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%